ViroGates A/S ViroGates has developed a unique prognostic biomarker - suPARnostic®, measuring the soluble blood protein suPAR, present in everybody. Independent of the respective condition, an elevated suPAR level is a master alarm for a patient's risk status. In clinical practice suPARnostic® can be used for patient triaging in critical care as well as monitoring of treatment efficacy and success. suPARnostic®'s amazing prognostic value has already been exemplified in various infectious conditions, these include sepsis/SIRS, tuberculosis and HIV.